Literature DB >> 20670084

Use of rituximab in combination with high-dose methotrexate in the treatment of primary central nervous system lymphoma in a mycophenolate mofetil treated patient with lupus nephritis.

Gillianne Geet Yi Lai, Yu Xuan Koo, Miriam Tao, Thuan Tong Tan, Soon-Thye Lim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20670084     DOI： 10.3109/0284186X.2010.504231

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  5 in total

Review 1.  Primary central nervous system lymphoma in neuropsychiatric systemic lupus erythematosus: case-based review.

Authors:  Takanori Ichikawa; Yasuhiro Shimojima; Dai Kishida; Tomoki Kaneko; Yoshiki Sekijima
Journal:  Rheumatol Int       Date:  2020-04-06       Impact factor: 2.631

2.  Complications of immunosuppressive/immunomodulatory therapy in neurological diseases.

Authors:  Avindra Nath; Joseph R Berger
Journal:  Curr Treat Options Neurol       Date:  2012-06       Impact factor: 3.598

3.  Relapsed and refractory primary CNS lymphoma: treatment approaches in routine practice.

Authors:  Prakash Ambady; Nancy D Doolittle; Christopher P Fox
Journal:  Ann Lymphoma       Date:  2021-09

4.  Eosinophilic granulomatosis with polyangiitis (EGPA) on remission with a new neuropathy: a rare case of mycophenolate induced primary CNS lymphoproliferative disease.

Authors:  Pragya Shrestha; Ian Garrahy; Shoja Rahimian
Journal:  J Community Hosp Intern Med Perspect       Date:  2020-10-29

5.  Tripterygium and its plant extraction for systemic lupus erythematosus: A protocol for systematic review and meta analysis.

Authors:  Fangying Chen; Junting Liu; Zhimin Zhao; Ziping Li; Kuanyu Wu
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.